BeOne Medicines AG (SHA:688235)
279.25
-0.98 (-0.35%)
Dec 5, 2025, 3:00 PM CST
BeOne Medicines AG Employees
BeOne Medicines AG had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
3.22M CNY
Profits / Employee
44.37K CNY
Market Cap
252.62B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 20,238 |
| WuXi AppTec | 39,414 |
| Shenzhen Mindray Bio-Medical Electronics | 21,667 |
| Sichuan Biokin Pharmaceutical | 2,521 |
| Shanghai United Imaging Healthcare | 8,173 |
| Aier Eye Hospital Group | 42,693 |
| Zhangzhou Pientzehuang Pharmaceutical., | 2,839 |
| Yunnan Baiyao Group Co.,Ltd | 9,277 |
BeOne Medicines AG News
- 4 weeks ago - BeiGene Non-GAAP EPADS of $2.65, revenue of $1.4B beats by $40M - Seeking Alpha
- 4 weeks ago - BeiGene Q3 2025 Earnings Preview - Seeking Alpha
- 3 months ago - BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up - Benzinga
- 4 months ago - A Glimpse of BeiGene's Earnings Potential - Benzinga
- 4 months ago - BeiGene's Earnings: A Preview - Benzinga
- 4 months ago - BeiGene Q2 2025 Earnings Preview - Seeking Alpha
- 5 months ago - Glenmark Pharmaceuticals launches TEVIMBRA in India for advanced lung and esophageal cancer treatment - Business Upturn
- 6 months ago - Glenmark Pharmaceuticals to launch Zanubrutinib (BRUKINSA) in India after DCGI approval - Business Upturn